Watch SBCWW. Know when insiders buy.
One email the day a filing lands. Free.
SBCWW
SBC Medical Group Holdings Inc
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $175.2M −6.9%NET INCOME $49M +47.1%NET CASH $146.6M52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $49.2M | +13.4% | 73.1% | $19M | $10.7M | +335.0% | 0.10 | $22.5M | $84K | $22.4M | Aug 13 |
| Q1 2026 · Mar 31 | $43.1M | −9.0% | 70.5% | $17.7M | $11.3M | −47.4% | 0.11 | $9.2M | $125K | $9.1M | May 14 |
| Q4 2025 · Dec 31derived | $39.6M | −10.9% | 73.1% | $12.8M | $14.2M | +117.2% | 0.14 | $52M | $798K | $51.2M | Mar 27 |
| Q3 2025 · Sep 30 | $43.4M | −18.3% | 70.6% | $15.9M | $12.8M | +352.7% | 0.12 | −$20.9M | $43K | −$20.9M | Nov 14 |
| Q2 2025 · Jun 30 | $43.4M | −18.3% | 69.2% | $14.6M | $2.5M | −86.7% | 0.02 | −$8.3M | $307K | −$8.6M | Aug 13 |
| Q1 2025 · Mar 31 | $47.3M | −13.6% | 79.7% | $24.2M | $21.5M | +14.6% | 0.21 | $1.9M | $254K | $1.7M | May 14 |
| Q4 2024 · Dec 31derived | $44.4M | −28.8% | 76.3% | $4.7M | $6.5M | −54.4% | 0.06 | −$7.3M | $590K | −$7.9M | Mar 27 |
| Q3 2024 · Sep 30 | $53.1M | +12.3% | 81.5% | $13.8M | $2.8M | −66.1% | 0.03 | $5M | $409K | $4.6M | Nov 14 |
| Q2 2024 · Jun 30 | $53.1M | — | 74.2% | $27.3M | $18.5M | — | 0.20 | $19.2M | $863K | $18.3M | Aug 13 |
| Q1 2024 · Mar 31 | $54.8M | — | 72.1% | $24.5M | $18.8M | — | 0.20 | $3.7M | $702K | $3M | May 15 |
| Q4 2023 · Dec 31derived | $62.3M | — | 69.6% | $24M | $14.3M | — | 0.15 | $27.9M | $6.2M | $21.7M | Mar 28 |
| Q3 2023 · Sep 30 | $47.3M | — | 70.9% | $20M | $8.4M | — | 0.09 | $24.1M | — | — | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $173.6M | 73.3% | $67.5M | $51M | 29.4% | 0.50 | $24.7M | $1.4M | $23.3M | $5M | — |
| FY2024 · to Dec 31 | $205.4M | 76.0% | $70.3M | $46.6M | 22.7% | 0.48 | $20.6M | $2.6M | $18M | $0 | — |
| FY2023 · to Dec 31 | $193.5M | 70.9% | $70.7M | $39.4M | 20.3% | 0.42 | $50.7M | $8.5M | $42.1M | — | — |
Every number comes from SBC Medical Group Holdings Inc's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.